Citigroup »

Entero Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Entero Therapeutics (GRDX) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Entero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entero Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entero Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $2 1 2.00

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Entero Therapeutics

Federation des caisses Desjardins du Quebec
Geode Capital Management
Renaissance Technologies
State Street Corporation
Vanguard Group
Vanguard Capital Management
Vanguard Fiduciary Trust
Jane Street
Harbour Investments
UBS Group
SBI Securities
Advisor Group Holdings
Danske Bank A/s
Citigroup

View all funds holding Entero Therapeutics